Sahara AI’s SAHARA token experienced a sharp 45% plunge, hitting an intraday low. Locked token concerns and recent unlocks contributed to the decline. Sahara AI’s token, SAHARA, experienced a sharp drop. According to Binance market data, this occurred at 23:24 UTC+8. It fell to an intraday low of $0.0346. It is currently trading at $0.04426. […] The post SAHARA Token Plunges 45% as Price Hits Intraday Low appeared first on Live Bitcoin News.Sahara AI’s SAHARA token experienced a sharp 45% plunge, hitting an intraday low. Locked token concerns and recent unlocks contributed to the decline. Sahara AI’s token, SAHARA, experienced a sharp drop. According to Binance market data, this occurred at 23:24 UTC+8. It fell to an intraday low of $0.0346. It is currently trading at $0.04426. […] The post SAHARA Token Plunges 45% as Price Hits Intraday Low appeared first on Live Bitcoin News.

SAHARA Token Plunges 45% as Price Hits Intraday Low

Sahara AI’s SAHARA token experienced a sharp 45% plunge, hitting an intraday low. Locked token concerns and recent unlocks contributed to the decline.

Sahara AI’s token, SAHARA, experienced a sharp drop. According to Binance market data, this occurred at 23:24 UTC+8. It fell to an intraday low of $0.0346. It is currently trading at $0.04426. This is down about 45.6% from the 24-hour high of $0.08141. The team has not come out to respond to the price movement.

SAHARA Token Suffers Significant Price Correction

Market analyst “Bitget Insights” said there was a bearish shift. This was after the token rejected an ascending trendline. It was lower than the horizontal support. According to a November 13, 2025, video by Sarmaaya Financials, there is a significant red flag. This was with 75% of SAHARA tokens still being locked. This resulted in potential selling pressure on scheduled unlocks.

Related Reading: Crypto News: Tether Ends Bitcoin Mining Operation In Uruguay Due To “High Energy Costs” | Live Bitcoin News

A token unlock event was plotted for November 26, 2025. This probably had an influence on the recent fall in prices. Sahara AI (SAHARA) is a decentralized platform. It is based on a layer-1 blockchain. This democratizes artificial intelligence (AI) development. The native utility token is the SAHARA token. It gets used for different purposes.

Accessing and licensing AI assets such as datasets and models. Paying for AI agents by the inference stake to provide security to the network. Participating in governance decisions via the Sahara DAO.

Token Unlocks and Bearish Indicators Drive Downturn

The large decline in SAHARA’s price paves a huge selling pressure. This took place soon after a token unlock event. Such events often put more supply into the market. This can depress prices.

The absence of any official response from the Sahara AI team is notable. This quiet could further add to investor uncertainty. It could lead to an additional price fluctuation.

The concerns about the remaining 75% of tokens being locked up are critical. Scheduled unlocks, furthermore, represent future selling pressure. This provides a difficult setting for long-term price stability.

Sahara AI's SAHARA token experienced a sharp 45% plunge, hitting an intraday low. Locked token concerns and recent unlocks contributed to the decline.                                                               Source: Binance

Investors such as Pantera Capital and Polychain have invested in Sahara AI. Their past investments reflect initial confidence in the project. However, performance in recent markets has been divergent.

The technical analysis by “Bitget Insights” provides a good perspective. The rejection of an ascending trendline and the move below the support are strong bearish signals. These are indications of a change in market momentum.

Sahara AI’s vision to democratize the development of AI is ambitious. The SAHARA token’s utility inside its ecosystem is diverse. It supports different functions ranging from access to governance.

However, strong fundamentals can be cast into the dark. This occurs through the dynamics of supply and the general feeling in the market. The present, the price action of SAHARA, is a vivid example of this challenge.

The incident highlights the inherent risks of cryptocurrency investments. Token Unlocks, combined with bearish market indicators, require careful monitoring. Investors should monitor the development of the projects.

The post SAHARA Token Plunges 45% as Price Hits Intraday Low appeared first on Live Bitcoin News.

Market Opportunity
SaharaAI Logo
SaharaAI Price(SAHARA)
$0,02685
$0,02685$0,02685
-0,92%
USD
SaharaAI (SAHARA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26